Quick Links

Accreditation/Designation of Credit Statementc

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Aimmune Therapeutics.

Clinical Practice Connections™: From Diagnosis to Emerging Immunotherapeutic Options: Understanding the Burden and Risks in Peanut Allergy

Release Date: September 28, 2018
Expiration Date: September 28, 2019
Media: Internet - based

Activity Overview

Of all food allergies, peanut allergies cause the most severe cases of anaphylaxis and represent the leading cause of death from food-induced anaphylaxis. With a prevalence of approximately 2% of the US population, there is no clear-cut understanding of why peanut allergies have continued to increase. Furthermore, not only are patients and caregivers burdened with strict avoidance at all times and constant wariness of accidental exposure but with additional costs of outpatient and emergency visits or hospitalizations for severe reactions. However, a paradigm shift in peanut allergy management is evolving. In this Clinical Practice Connections™, expert faculty will address myths and misconceptions about food allergies, outline appropriate diagnosis and provide expert panel addendum guideline recommendations for early introduction of peanut protein to infants at various risk levels. Children and adults with peanut allergies may soon benefit from ongoing clinical trials of desensitization treatments as faculty describe three emerging immunotherapies and considerations for incorporation into practice.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Aimmune Therapeutics.

Target Audience

This CME activity is primarily intended for allergists, immunologists, primary care physicians, pediatricians, and clinicians who treat patients with peanut allergy.

Educational Objectives

At the conclusion of this activity, you should be better prepared to:

  • Elaborate on the prevalence and psychosocial burden of peanut allergies for patients and caregivers
  • Identify key studies and guideline recommendations for early introduction of peanuts
  • Describe considerations for implementation of upcoming immunotherapies into clinical practice

Faculty, Staff, and Planners' Disclosures


David R. Stukus, MD
Associate Professor of Pediatrics
Division of Allergy and Immunology
Nationwide Children’s Hospital and The Ohio State University College of Medicine
Columbus, Ohio

Disclosure: No relevant financial information to disclose

The staff of Physicians' Education Resource®, LLC, (PER®) have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.

Become a Member

Forgot Password?
Filter By